Dimethyl fumarate and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Dimethyl fumarate and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dimethyl fumarate
Brand name: Tecfidera, Tecfidera Starter Pack
Synonyms: Dimethyl Fumarate
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dimethyl fumarate-Insulin degludec
- Dimethyl fumarate-Insulin Degludec (U-100) Prefilled Pens
- Dimethyl fumarate-Insulin Degludec (U-100) Vials
- Dimethyl fumarate-Insulin Degludec (U-200) Prefilled Pens
- Dimethyl fumarate-Insulin degludec and liraglutide
- Dimethyl fumarate-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Dimethyl sulfoxide
- Insulin aspart, recombinant Subcutaneous-Dimethyl sulfoxide Intravesical
- Insulin aspart, recombinant Subcutaneous-Dino-Life
- Insulin aspart, recombinant Subcutaneous-Dinoprostone
- Insulin aspart, recombinant Subcutaneous-Dinoprostone Cervical Gel
- Insulin aspart, recombinant Subcutaneous-Dinoprostone topical